Quantcast

Latest Amgen Inc. Stories

2014-06-02 08:29:32

Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from two key clinical trials that support the potential of talimogene laherparepvec, a novel, investigational oncolytic immunotherapy, as both a single agent and as part of a combination regimen in patients with metastatic melanoma. The findings were presented at the 50th...

2014-05-30 08:23:32

Editor Note: For more information about this release, please scroll to bottom. On Thursday, May 29, 2014, the NASDAQ Composite ended at 4,247.95, up 0.54%, the Dow Jones Industrial Average advanced 0.39%, to finish the day at 16,698.74, and the S&P 500 closed at 1,920.03, up 0.54%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index ended the day at 688.45, up 0.76%, with the index advancing 2.45%...

2014-03-19 08:25:57

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, March 19, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Amgen, Inc. (NASDAQ: AMGN), Zimmer Holdings, Inc. (NYSE: ZMH), Covidien plc (NYSE: COV), Laboratory Corporation of America Holdings (NYSE: LH), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership,...

2014-03-13 12:28:36

CHICAGO, March 13, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Herbalife Ltd (NYSE:HLF-Free Report), Nu Skin Enterprises Inc (NYSE:NUS-Free Report), Avon Products Inc (NYSE:AVP-Free Report), Bayer (OTC:BAYRY-Free Report) and Amgen Inc. (Nasdaq:AMGN-Free Report)....

2014-02-06 23:24:53

MarketResearchReports.Biz announces addition of new report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description” to its database. Visit: http://www.marketresearchreports.biz/analysis/186872 Albany, NY (PRWEB) February 06, 2014 Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description Research...

2014-01-28 16:25:52

2013 GAAP EPS Were $6.64 THOUSAND OAKS, Calif., Jan. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2013. Key results include: -- For the fourth quarter, total revenues increased 13 percent to $5,011 million, with product sales growing at 11 percent. Adjusted EPS grew 30 percent to $1.82, with higher revenues, the end of the Enbrel(®) (etanercept) profit share, and a lower tax rate partially...

2014-01-22 12:23:39

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Pharmerging Markets 2012-2016TechNavio's analysts forecast the Pharmerging market to grow at a CAGR of 12.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in healthcare spending. The Pharmerging market has also been witnessing an increase in partnerships among vendors. However, the price pressure could pose a challenge to the...

2013-12-07 23:02:25

MarketReportsOnline.com offers “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” in its store. Key drug manufacturers of the global rheumatoid arthritis market like Abbvie Inc. (Humira), Amgen Inc. (Enbrel), Johnson & Johnson (Remicade), Roche Holdings AG (Actemra) are profiled in the report. Dallas, TX (PRWEB) December 07, 2013 The report titled "Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)" provides an in-depth...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related